NFE2L2 and non-small cell lung carcinoma: Studies on non-small cell lung cancer (NSCLC), both preclinical and clinical, have demonstrated tight relationships among the resistance to chemotherapy, radiation therapy, and other agents, and the loss of function of Keap1 and overexpression of Nrf2.